This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Antibody Engineering & Therapeutics Europe
10 - 12 June, 2025
Congress CenterBasel Switzerland

Obinna Ubah, PhD
Principal Scientist and Future Leaders Fellow at Elasmogen Limited
Speaker

Profile

Obinna heads the Immunology drug discovery and development at Elasmogen Limited. His research broadly encompasses biologics drug discovery and development for chronic diseases, including autoimmune inflammatory diseases and cancers. Obinna is a trained pharmacist and holds a master’s degree in clinical pharmacology and toxicology, as well as a PhD in molecular biology and biotechnology. He is a fellow of the UK Higher Education Academy and holds an honorary lectureship position at the University of Aberdeen, Scotland. He currently holds the prestigious UKRI Future Leaders Fellowship award of £2M, supporting his cutting-edge drug discovery research and leadership development.

Agenda Sessions

  • First-in-class Site-directed Targeted soloMER Drug Conjugate for Autoimmune Inflammation

    09:30